Infliximab (Anti-TNF-alpha) (Avakine (Anti-TNF-alpha)) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-alpha. Infliximab (Anti-TNF-alpha) prevents the interaction of TNF-alpha with TNF-alpha receptor (TNFR1 and TNFR2). Infliximab (Anti-TNF-alpha) has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research[1][2].
Molekulargewicht:
(145.886 kDa)
Reinheit:
99.00
Target-Kategorie:
TNF Receptor
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten